These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8159647)

  • 1. Assessment of Ki-67-derived tumor proliferative activity in colorectal adenocarcinomas.
    Sahin AA; Ro JY; Brown RW; Ordonez NG; Cleary KR; el-Naggar AK; Wilson P; Ayala AG
    Mod Pathol; 1994 Jan; 7(1):17-22. PubMed ID: 8159647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytometric ploidy and proliferative activity in colorectal carcinoma.
    Grigolato P; Berenzi A; Benetti A; Chirico E; Cadei M; Casella C; Salerni B; Lojacono L
    Eur J Histochem; 1994; 38(2):163-70. PubMed ID: 7524813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications.
    Berenzi A; Benetti A; Bertalot G; Rodolfi A; Portolani N; Giulini SM; Pulcini G; Vinco A; Tiberio G
    Pathologica; 1992; 84(1090):155-63. PubMed ID: 1437304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
    Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
    Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The malignancy potential of colorectal polyps--histomorphometric, histochemical and immunohistochemical study of the dysplasia-carcinoma sequence].
    Dippe B; Petrowsky H; Krüger S; von Jentzkowski K; Schneider M; Lorenz M
    Zentralbl Chir; 1995; 120(7):556-63. PubMed ID: 7676754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical correlations of cyclin-dependent kinase inhibitors p21waf1/cip1 and p27kip1 in metastatic colorectal carcinoma.
    Cheng JD; Werness BA; Babb JS; Meropol NJ
    Clin Cancer Res; 1999 May; 5(5):1057-62. PubMed ID: 10353738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations.
    Shepherd NA; Richman PI; England J
    J Pathol; 1988 Jul; 155(3):213-9. PubMed ID: 3411382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
    Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
    Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma.
    Ono T; Miki C
    Am J Gastroenterol; 2000 Apr; 95(4):1062-7. PubMed ID: 10763960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
    Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
    Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.